Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. [PDF]
Singh S, Kumar S, Luthra K.
europepmc +1 more source
HIV-1 gp120 Induces Nociceptive Hypersensitivity via α2δ-1-Bound NMDA Receptors at Primary Afferent→Excitatory Neuron Synapses. [PDF]
Gautam V +4 more
europepmc +1 more source
Crystal structure of HERV-K envelope glycoprotein surface subunit. [PDF]
Nikolopoulos N, Modis Y.
europepmc +1 more source
Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a <i>Gba1</i>-Deficient Synucleinopathy Model. [PDF]
Lagni A +9 more
europepmc +1 more source
The prefrontal cortex as a target of HIV-1 neurotoxicity: molecular mechanisms of viral protein-mediated neurodegeneration and executive dysfunction. [PDF]
Honsa ES.
europepmc +1 more source
From Envelope to Encephalopathy: How HIV-1 gp120 Drives Neurocognitive Decline. [PDF]
Santerre M +4 more
europepmc +1 more source
Natural variations at the E433 site in Env-gp120 β20-β21 cooperate with V2 and gp41 mutations to modulate HIV-1 infectivity. [PDF]
Le BQ +10 more
europepmc +1 more source
HIV inhibits Warburg metabolism in human macrophages infected with Mycobacterium tuberculosis. [PDF]
Brown K +10 more
europepmc +1 more source
Cutting-edge developments in computer-aided anti-HIV drug design. [PDF]
Yang W, Wang Y, Feng C, Tang W, Sun L.
europepmc +1 more source
Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies. [PDF]
Dasgupta S +5 more
europepmc +1 more source

